News - Management, North America

Filter

Current filters:

ManagementNorth America

Popular Filters

Biopharma stepping up to improve STEM education in USA, new Battelle report finds

23-01-2014

In the USA, innovative biopharmaceutical companies and their corporate foundations are making significant…

ManagementNorth AmericaPharmaceuticalUSA

Domain Therapeutics opens North American subsidiary

20-01-2014

French biopharma company Domain Therapeutics, specializing in the R&D of new drug candidates targeting…

BiotechnologyCanadaDomain TherapeuticsManagementNorth America

Eisai’s R&D organization undergoes “transformation”

Eisai’s R&D organization undergoes “transformation”

30-11-2013

Japanese drugmaker Eisai's president and chief executive, Haruo Naito, says that the company's R&D organization,…

Asia-PacificEisaiEuropeManagementNorth AmericaPharmaceuticalResearchUSA

Actavis cuts 350 sales staff after acquisition of Warner Chilcott

Actavis cuts 350 sales staff after acquisition of Warner Chilcott

22-11-2013

US generics major Actavis (NYSE: ACT) says it has completed the restructuring of its US Specialty Brands…

ActavisFinancialGenericsManagementNorth AmericaUSAWarner Chilcott

Amarin cuts 50% of staff after negative FDA decision

23-10-2013

Amarin has announced plans to cut 50% of its staff worldwide after the recent US Food and Drug Administration…

AmarinCardio-vascularFinancialManagementNorth AmericaPharmaceuticalVascepa

Eisai to double Belviq sales force by December

Eisai to double Belviq sales force by December

15-10-2013

Eisai’s US subsidiary will increase its force for the obesity drug Belviq to around 400 representatives…

Arena PharmaceuticalsBelviqEisaiManagementMarkets & MarketingMetabolicsNorth AmericaPharmaceutical

Adjusting relationship models offers a path to greater performance and efficiency, says Tufts CSDD

08-10-2013

While drug sponsor use of strategic relationships with contract service providers has increased dramatically…

ManagementNorth AmericaPharmaceuticalResearch

Almirall sets up new affiliate to support Canadian product launches

06-09-2013

Spain's largest pharma company, Almirall (ALM: MC) has continued its expansion with the launch of a new…

AlmirallManagementMarkets & MarketingNorth AmericaPharmaceuticalTudorza Genuair

Novo Nordisk makes US appointment; gets appro for NovoPen Echo

21-08-2013

Danish insulin giant Novo Nordisk (NOV: N) said late yesterday (August 21) that Jesper Hoiland has been…

DiabetesManagementNorth AmericaNovo NordiskNovoPen EchoPharmaceuticalRegulation

Vivus reaches agreement with First Manhattan and appoints new board

19-07-2013

A truce has been called between US drugmaker Vivus (Nasdaq: VVUS) and its top investor First Manhattan…

ManagementNorth AmericaPharmaceuticalVivus

US Senate confirms appointment of Marilyn Tavenner as CMS Administrator

16-05-2013

US Health and Human Services (HHS) Secretary Kathleen Sebelius announced that the US Senate has confirmed…

BiotechnologyGenericsHealthcareManagementNorth AmericaPharmaceutical

Briefs: Pfizer $142 million fine upheld; Bristol-Myers shuts Amylin facility

05-04-2013

The US Court of Appeals in Boston has upheld a $142.1 million damage award to Kaiser Foundation Health…

AmylinBristol-Myers SquibbLegalManagementMarkets & MarketingNeurontinNorth AmericaPfizerPharmaceutical

Top strategic priorities for Big Pharma marketing and sales execs in 2013; Accenture survey

26-03-2013

Senior sales and marketing executives of large US pharmaceutical companies - with corporate revenues…

ManagementMarkets & MarketingNorth AmericaPharmaceutical

New US Federal Trade Commission chairman - Edith Ramirez - to be designated by President

03-03-2013

President Barack Obama intends to designate Edith Ramirez as Chairman of the Federal Trade Commission…

BiotechnologyGenericsManagementNorth AmericaPharmaceuticalRegulation

Biopharma facing hiring difficulties and R&D talent gap, PwC unit finds

04-02-2013

A talent gap in the scientific workforce has biopharmaceutical companies searching outside for fresh…

BiotechnologyManagementNorth AmericaPharmaceuticalResearch

US Pharma execs most concerned about the changing commercial business model

04-12-2012

Results of a new survey illustrate evolutions on business models, next generation technical trends and…

ManagementNorth AmericaPharmaceutical

Patient adherence efforts gain more recognition throughout US pharma industry

14-10-2012

Since 2009, US pharmaceutical companies have increased their patient adherence budgets by 281%, according…

BiotechnologyManagementMarkets & MarketingNorth AmericaPharmaceutical

Biotech industry R&D spending jumps 5% in 2011, BDO Study Finds; Exec salaries

20-09-2012

Research and development expenditures in the biotechnology industry grew 5% in 2011, bouncing back after…

BiotechnologyFinancialManagementNorth AmericaResearch

Pharmaceutical sales rep access reducing most among oncologists in USA

28-08-2012

As more pharmaceutical companies prepare to bring new oncology drugs to market, their sales representatives…

BiotechnologyManagementMarkets & MarketingNorth AmericaOncologyPharmaceutical

LEO Pharma sales reps file suit on overtime in USA

09-02-2012

Attorneys from Sanford Wittels & Heisler have filed a class action complaint in the US District Court…

LegalLEO PharmaManagementNorth AmericaPharmaceutical

Novartis resolves US class action on wage and hour claims

25-01-2012

The US subsidiary of Swiss drug major Novartis (NOVN: VX) says it has reached an agreement to resolve…

LegalManagementNorth AmericaNovartisPharmaceutical

Vertex updates on US and EU Kalydeco filings; to get new CEO

16-12-2011

US drugmaker Vertex Pharmaceuticals (Nasdaq: VRTX) says that the US Food and Drug Administration has…

EuropeKalydecoManagementNorth AmericaPharmaceuticalRare diseasesRegulationVertex

AstraZeneca expands in China, cuts back in USA

08-12-2011

It was a busy couple of days for Anglo-Swedish drug major AstraZeneca (LSE: AZN), with the company yesterday…

Asia-PacificAstraZenecaGenericsGuangdong BeiKang PharmaManagementMergers & AcquisitionsNorth AmericaPharmaceutical

Moves to bar Forest CEO from US health care contracts dropped by HHS-OIG

08-08-2011

week of high-profile activity for US drugmaker Forest Laboratories (NYSE: FRX), there was welcome news…

Forest LaboratoriesLegalManagementNorth AmericaPharmaceutical

Back to top